Primer Karaciğer Kanserlerinin Yönetimi ve Tedavisi

Türkiye Kanserle Savaş Vakfı, Kanser Gündemi Dergisi, Primer Karaciğer Tümörleri Volume 5.3

NCCN Guidelines Version 4.2024 Hepatocellular Carcinoma

Shah ZK, McKernan MG, Hahn PF, Sahani DV. Enhancing and expansile portal vein thrombosis: value in the diagnosis of hepatocellular carcinoma in patients with multiple hepatic leisons. AJR Am J Roentgenol 2007; 188: 1320-1323.

Amano S, Ebara M, Yajima T, et al. Assessment of cancer cell differentiation in small hepatocellular carcinoma by computed tomography and magnetic resonance imaging. J Gastroenterol Hepatol. 2003; 18: 273-279.

Grieco A, Pompili M, Caminiti G, et al. Prognostic factors for survival in patients with early-intermediate hepatocellular carcinoma undergoing nonsurgical therapy: comparison of Okuda, CLIP, and BCLC staging systems in a single Italian centre. Gut 2005; 54: 411-418.

Orlando A, Leandro G, Olivo M, et al. Radiofrequency thermal ablation vs. percutaneous ethanol injection for small hepatocellular carcinoma in cirrhosis: meta-analysis of randomized controlled trials. Am J Gastroenterol. 2009; 104 (2): 514-24.

Yu SJ. A concise review of updated guidelines regarding the management of hepatocellular carcinoma around the world: 2010-2016. Clin Mol Hepatol. 2016 Mar; 22(1): 7-17. doi: 10.3350/cmh. 2016. 22.1.7.

European Association For The Study Of The Liver; European Organisation For Research And Treatment Of Cancer. EASL-EORTC clinical practice KAYNAKLAR PRİMER KARACİĞER KANSERLERİNDE TANI VE KLİNİK 39 guidelines: management of hepatocellular carcinoma.J Hepatol. 2012 Apr; 56 (4): 908-43. doi: 10.1016/j. jhep. 2011.12.001.

Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015 Mar; 65(2): 87-108.

Llovet JM, Brú C, Bruix J. Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis. 1999; 19 (3): 329-38.

Chapman R1, Fevery J, Kalloo A, Nagorney DM, Boberg KM, Shneider B, Gores GJ; American Association for the Study of Liver Diseases. Diagnosis and management of primary sclerosing cholangitis. Hepatology. 2010 Feb; 51 (2): 660-78. doi: 10.1002/hep.23294.

Fazakas J Mándli T, Ther G, Arkossy M, Pap S, Füle B, Németh E, Tóth S, Járay J. Evaluation of liver function for hepatic resection. Transplant Proc. 2006; 38: 798-800

Pang TC, Lam VW. Surgical management of hepatocellular carcinoma. World J Hepatol. 2015 Feb 27; 7: 245-52

Ikai I, Arii S, Kojiro M, Ichida T, Makuuchi M, Matsuyama Y, Nakanuma Y, Okita K, Omata M, Takayasu K, Yamaoka Y. Reevaluation of prognostic factors for survival after liver resection in patients with hepatocellular carcinoma in a Japanese nationwide survey. Cancer. 2004 Aug 15; 101: 796-80

Choi SB, Kim KS, Choi JY, et al. The prognosis and survival outcome of intrahepatic cholangiocarcinoma following surgical resection: association of lymph node metastasis and lymph node dissection with survival. Ann Surg Oncol 2009; 16: 3048-56

Mazzaferro V, Regalia E, Doci R, et al: Liver transplantation for the treatment of small hepatoKAYNAKLAR PRİMER KARACİĞER TÜMÖRLERİ TEDAVİSİNDE KARACİĞER TRANSPLANTASYONU 49 cellular carcinomas in patients with cirrhosis, N Engl J Med, 1996; 334, 693-699

Prasad KR, Young RS, Burra P, et al: Summary of candidate selection and expanded criteria for liver transplantation for hepatocellular carcinoma: a review and consensus statement, Liver Transpl, 2011: 17 (suppl 2), S81-89